At Revolution Medicines, we aim to change the trajectory of disease for patients living with RAS-addicted cancers around the world. We challenge assumptions, act on what the science reveals, and push beyond convention to tackle some of the most difficult-to-treat cancers.
Our differentiated, platform-driven approach targets RAS in its active, ON state—unlocking a fundamentally new way to inhibit RAS. We are advancing a broad, integrated pipeline of inhibitors with the ambition to establish RAS(ON) inhibition as the backbone for treating RAS-addicted cancers while continuing to pioneer the next generation of innovation.
We follow the science and act on it with urgency to turn insights into new treatments—because for patients, the stakes are deeply personal, measured in time and quality of life.
We believe that science-powered innovation creates possibilities. As a privately held, fully-integrated global company, Revance is passionately driven by that philosophy in everything we do. Dedicated to offering a diverse portfolio in aesthetics, skincare, and therapeutics, our science-backed products care for individuals across the generations. By driving innovation beyond convention, we continue to research and develop differentiated products for health, beauty, and wellness.
Canoo’s mission is to bring EVs to everyone.
Unlike anything on the road today, Canoo has developed breakthrough electric vehicles that are reinventing the automotive landscape with bold innovations in design, pioneering technologies, and a unique business model that spans all owners in the full lifecycle of the electric vehicle.